Global Veterinary Antibiotic Market Report
Global Veterinary Antibiotic Market by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry, and Others), Drug Class (Tetracyclines, Penicillin, Macrolides, Trimethoprim, Sulfonamides, Lincosamides, Aminoglycosides, Polymyxins, Pleuromu tilin, Fluoroquinolones, and Others), Dosage Form (Oral Powder, Oral Solution, Injection, and Others), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Veterinary Antibiotic Overview
Animals can get bacterial diseases treated and prevented with the use of antibiotics. Over the years, the need for veterinary antibiotics has increased steadily on a global scale. The rise in pet ownership, the increased demand for goods generated from animals, such as meat and milk, and the necessity to maintain livestock health in the agriculture sector are all factors contributing to this expansion.
Veterinary antibiotics include oral drugs, injectables, and topical preparations. The market includes a wide range of antibiotic classes, including cephalosporins, aminoglycosides, fluoroquinolones, penicillin, tetracyclines, and fluoroquinolones, among others. Animals kept as pets and cattle both receive veterinary antibiotics. Several animal species, including dogs, cats, cattle, pigs, chickens, horses, and fish, are given them.
Global Veterinary Antibiotic Market Analysis
The global veterinary antibiotic market size was $4,962.0 million in 2022 and is predicted to grow with a CAGR of 4.1%, by generating a revenue of $7,363.0 million by 2032.
COVID-19 Impact on Global Veterinary Antibiotic Market
The veterinary antibiotic business is just one of the industries that have been impacted by the COVID-19 outbreak. Animal hospitals and veterinary clinics continued to operate so that animals can receive the proper care, including when antibiotics are necessary. Due to lockdowns and other social isolation measures, the pandemic resulted in an increase in pet ownership among individuals and families as psychological support. The demand for veterinary services and, consequently, veterinary antibiotics increased as a result of the rise in pet ownership.
Several changes are anticipated to occur in the veterinary antibiotic market as we go into the post-COVID-19 future. The veterinary antibiotic market is projected to revive and resume its growth trajectory with the lifting of restrictions and restart of economic activity. As veterinary clinics and animal healthcare facilities resume regular business operations, the need for veterinary services and antibiotics is anticipated to increase. The pandemic has highlighted the value of protecting animal health and preventing the spread of zoonotic diseases. There is a persistent need for veterinary antibiotics as part of infection prevention and treatment because pet owners and livestock farmers are required to maintain a high level of vigilance on the health and wellbeing of animals.
Rising Pet Ownership to Drive the Market Growth
The market for veterinary antibiotics is significantly fueled by the expanding trend of pet ownership around the world. The need for veterinary services, including the usage of antibiotics, rises as more people accept pets into their families. There is a greater need for antibiotics as a result of pet owners seeking medical care to maintain the health of their animals. The demand for veterinary antibiotics is driven by the incidence of infectious illnesses in both livestock and companion animals. Antibiotics are necessary for the treatment and management of bacterial infections, preserving the health and wellbeing of animals. The demand for veterinary antibiotics is driven by the rise of the livestock industry to meet the rising demand for meat, dairy, and other animal-derived goods. In order to maintain the health and production of cattle, bacterial infections must be prevented and treated with antibiotics.
To know more about global veterinary antibiotic market drivers, get in touch with our analysts here.
Antimicrobial Resistance to Limit the Market Growth
The market for veterinary antibiotics faces a sizable problem as a result of the emergence and spread of antimicrobial resistance. Antibiotic overuse, abuse, and improper administration can result in the emergence of resistant bacterial strains, which reduces the potency of currently available antibiotics. Responsible antibiotic use and the investigation of alternative therapeutic alternatives are mandated by the growing AMR issue. The use of specific antibiotics in veterinary medicine is regulated by regulatory authorities. Due to their possible influence on human health, environmental issues, or the emergence of resistance, some antibiotics may be restricted or banned. These limitations may reduce the use and accessibility of particular medicines in the veterinary antibiotic market. New veterinary antibiotics may require a lengthy, expensive, and complicated approval process. The launch of novel antibiotics on the market may be hampered by stringent guidelines and specifications for safety and efficacy evaluation. This may reduce the variety of cutting-edge therapy choices available to vets and pet owners.
Development of Novel Antibiotics to Drive Excellent Opportunities
The creation of novel antibiotics with increased efficacy and decreased risk of microbial resistance is required. Investment opportunities exist for pharmaceutical firms and academic institutions in the discovery and development of new antibiotics that focus on certain pathogens or deal with resistance mechanisms. There are prospects for alternative medicines in veterinary medicine because of the rising worries about antibiotic resistance and the demand for sustainable therapeutic choices. For the prevention and treatment of bacterial infections in animals, research and funding in fields like vaccines, probiotics, phage therapy, immunotherapy, and nutraceuticals offer viable alternatives to antibiotics. The One Health concept offers chances for cooperation and teamwork in the fight against infectious illnesses because it acknowledges the interdependence of human, animal, and environmental health. In order to combat antimicrobial resistance holistically, the veterinary antibiotic industry can gain from coordinated programs that incorporate stakeholders from human medical, veterinary medicine, agriculture, and environmental sectors.
To know more about global veterinary antibiotic market opportunities, get in touch with our analysts here.
Global Veterinary Antibiotic Market Share, by Animal Type, 2022
The cattle sub-segment accounted for the highest market share in 2022. Cattle are grown for the production of meat and dairy products. The vast number of cattle present on the planet contributes to a high need for veterinary antibiotics. Throughout the world, cattle farming has a big economic impact on many areas. Keeping the animals healthy and productive is essential for the profitability and sustainability of cattle businesses. Compared to other livestock species like chickens or pigs, cattle live longer. This implies that cattle may need veterinary treatment, including the administration of antibiotics, for a longer period of time. Additionally, cattle may be more prone to persistent or chronic bacterial infections, demanding longer-term antibiotic therapy. These factors are anticipated to drive the growth of cattle sub-segment during the forecast period.
Global Veterinary Antibiotic Market Size, by Drug Class, 2022
The Penicillin sub-segment accounted for the highest market share in 2022. For many years, penicillin has been a common class of antibiotics in both human and veterinary medicine. Because penicillin has a broad spectrum of activity, it is effective against a variety of bacteria. It is frequently used to treat several bacterial illnesses in animals, including infections of the skin, urinary system, and soft tissues. Since penicillin has long been available in veterinary formulations, both veterinarians and pet owners can easily obtain them. Flexible administration options are made possible by the availability in a variety of forms, including injectables, oral formulations, and topical preparations. Comparing penicillin to several other classes of antibiotics, they are typically more affordable. They are a common option for treating bacterial infections in animals because of their affordability, especially when it is a major factor.
Global Veterinary Antibiotic Market Growth, by Dosage Form, 2022
The oral solution sub-segment accounted for the highest market share in 2022. A typical dose method for veterinary antibiotics is oral solutions. They provide a number of benefits for administering antibiotics to animals, especially to those who are difficult to treat with injectable formulations. Oral treatments are a practical choice for both veterinary experts and pet owners because they are quite simple to deliver to animals. They can be blended with the animal's food or water or given to it directly through the mouth using a syringe. Because they are simple to modify to deliver the correct dose dependent on the animal's weight or particular treatment requirements, oral solutions offer flexibility in dosing. This enables precise dosing and guarantees that antibiotics are delivered effectively to treat bacterial infections. The acceptance and compliance of animals are influenced by the oral solutions' palatability, making it a crucial factor to take into account. Oral solutions are frequently formulated by veterinary pharmaceutical companies to be tasty so that animals would swallow them more readily. It is possible to add flavoring agents to foods to enhance flavor and promote intake.
Global Veterinary Antibiotic Market Analysis, by Region, 2022
The North America veterinary antibiotic market generated the highest revenue in 2022. The considerable livestock output, high number of companion animals, sophisticated veterinary healthcare infrastructure, and regulatory frameworks all contribute to the sizeable veterinary antibiotic industry in North America. The market for veterinary antibiotics in North America is large. With a large selection of antibiotics accessible for use in animals, the region has a well-established veterinary pharmaceutical sector. The market is still expanding due to the rising focus on protecting the welfare of livestock and companion animals as well as the rising demand for animal health products. In North America, the market for veterinary antibiotics is significantly influenced by the companion animal industry. The need for antibiotics to treat bacterial infections in dogs, cats, and other companion animals is rising as pet ownership rates are rising and pet healthcare costs are rising. The market offers topical antibiotics, oral solutions, and tablets developed specifically for use in companion animals.
Competitive Scenario in the Global Veterinary Antibiotic Market
Investment and product development are common strategies followed by major market players. On July 2020, With the introduction of Cladaxxa, a broad-spectrum antibiotic with demonstrated efficacy in the targeted treatment of respiratory, digestive, urinary, skin, and dental infections in dogs and cats, Krka has expanded its line of companion animal products.
Some of the leading veterinary antibiotic market players are Zoetis Services LLC., Phibro Animal Health Corporation, Ceva, Merck & Co., Inc., Elanco, HIPRA, Dechra Pharmaceuticals Plc, Kyoritsu Seiyaku, Tianjin Ringpu, and Zydus.
Historical Market Estimations
Base Year for Market Estimation
Forecast Timeline for Market Projection
North America, Europe, Asia-Pacific, and LAMEA
Segmentation by Animal Type
Segmentation by Drug Class
Segmentation by Dosage form
Key Companies Profiled
Q1. What is the size of the global veterinary antibiotic market?
A. The size of the global veterinary antibiotic market was over $4,962.0 million in 2022 and is projected to reach $7,363.0 million by 2032.
Q2. Which are the major companies in the veterinary antibiotic market?
A. Tianjin Ringpu and Zydus are some of the key players in the global Veterinary Antibiotic market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The North America region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Product development and investment are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more on R&D practices?
A. Elanco and HIPRA are the companies investing more on R&D activities for developing new products and technologies.